📰 6 sources covering this story

‘It was like a godsend’ —GLP-1 drugs show promise against hormonal disorder that causes constant weight gain and forces women to shave facial hair

First covered 4 days ago · latest take 1 hrs ago. Compare how each outlet is covering it — and rate the sources you trust.

‘It was like a godsend’ —GLP-1 drugs show promise against hormonal disorder that causes constant weight gain and forces women to shave facial hair
Fortune
Fortune1 hrs ago
‘It was like a godsend’ —GLP-1 drugs show promise against hormonal disorder that causes constant weight gain and forces women to shave facial hair
“I didn’t understand why all this weight was coming back or why my friends didn’t have to shave their faces and I had to.”
CTV News
CTV News1 days ago
Obesity drugs show early promise against the hormonal disorder PMOS, giving a suffering family hope
A small but growing body of research shows that these obesity medications may also work for the disorder known as PMOS — not only by promoting weight loss but also by improving insulin resistance, hormone balance and ovulation.
The Independent
The Independent1 days ago
Obesity drugs show early promise against the hormonal disorder PMOS, giving a suffering family hope
A small but growing body of research shows that GLP-1 drugs often used to treat obesity may also work for the hormonal disorder known as PMOS
Obesity drugs show early promise against the hormonal disorder PMOS, giving a suffering family hope
A small but growing body of research shows that GLP-1 drugs often used to treat obesity may also work for the hormonal disorder known as PMOS
AP News
AP News1 days ago
Obesity drugs show early promise against the hormonal disorder PMOS, giving a suffering family hope
Obesity drugs show early promise against the hormonal disorder PMOS, giving a suffering family hope  AP News
Wall Street Journal
Wall Street Journal🏁 first to report4 days ago
Amgen Lifts Outlook on Strong Drug Sales, to End Early Development of Obesity Treatment
Amgen Lifts Outlook on Strong Drug Sales, to End Early Development of Obesity Treatment  wsj.com